Загрузка...
Anti‐IL5 therapies for asthma
BACKGROUND: This review is the first update of a previously published review in The Cochrane Library (Issue 7, 2015). Interleukin‐5 (IL‐5) is the main cytokine involved in the activation of eosinophils, which cause airway inflammation and are a classic feature of asthma. Monoclonal antibodies target...
Сохранить в:
| Опубликовано в: : | Cochrane Database Syst Rev |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6483800/ https://ncbi.nlm.nih.gov/pubmed/28933516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010834.pub3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|